Posted in | News | Business | Chemistry

SABIC and CB+I to Commercialize Toluene Methylation Technology

CB&I (NYSE:CBI) has signed an agreement with SABIC Americas to jointly develop and commercialize toluene methylation technology.

Toluene methylation is used to selectively produce paraxylene within an aromatics complex. The technology was developed around a proprietary SABIC catalyst and process.

“This agreement expands our paraxylene technologies within the polyester chain and complements our existing portfolio,” said Dan McCarthy, President of CB&I’s Lummus Technology sector. “It also provides a unique debottlenecking solution for aromatic complexes.”

Source: http://www.cbi.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.